Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 14/20 | 0.40 |
| ▸ | VEGFA | P15692 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | SELL | P14151 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12632766 | 0.80 | MEN1 (0.45) | SELPVEGFAPLA2G4AMEN1KMT2A | |
| SCHEMBL18308862 | 0.78 | SELP (0.42) | SELPVEGFAPLA2G4AAPP | |
| SCHEMBL14477819 | 0.77 | SELP (0.37) | SELPMEN1KMT2A | |
| SCHEMBL15281661 | 0.77 | MEN1 (0.53) | PLA2G4AMEN1KMT2A | |
| SCHEMBL12632771 | 0.77 | MEN1 (0.53) | PLA2G4AMEN1KMT2A | |
| SCHEMBL19827331 | 0.77 | MEN1 (0.53) | PLA2G4AMEN1KMT2A | |
| SCHEMBL14958606 | 0.75 | — | — | |
| SCHEMBL17035846 | 0.75 | — | — | |
| SCHEMBL18101943 | 0.75 | — | — | |
| SCHEMBL15281660 | 0.75 | MEN1 (0.50) | PLA2G4AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8551959-B2 | Glycolipid and use thereof | RIKEN (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20110104188-A1 | NOVEL GLYCOLIPID AND USE THEREOF | RIKEN (JP) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104188-A1 | NOVEL GLYCOLIPID AND USE THEREOF | SGMS1, UGCG, SGPL1 | SELP 1056/4885VEGFA 2143/4885PLA2G4A 565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.